JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lahoutte, T.
Right arrow Articles by Bossuyt, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lahoutte, T.
Right arrow Articles by Bossuyt, A.
Journal of Nuclear Medicine Vol. 44 No. 9 1489-1494
© 2003 by Society of Nuclear Medicine


Basic Science Investigations

Comparative Biodistribution of Iodinated Amino Acids in Rats: Selection of the Optimal Analog for Oncologic Imaging Outside the Brain

Tony Lahoutte, MD, John Mertens, PhD, Vicky Caveliers, PharmD, PhD, Philippe R. Franken, MD, PhD, Hendrik Everaert, MD, PhD and Axel Bossuyt, MD, PhD

Department of Nuclear Medicine, Academic Hospital, Free University Brussels, Jette, Belgium

3-123I-Iodo-{alpha}-methyltyrosine (123I-3-IMT) is used for the detection of residual and recurrent brain tumors. The application of 123I-3-IMT for the study of extracerebral malignancies is limited by its marked and rapid renal uptake. In this study, we compared the tumor uptake, biodistribution, and specificity of 5 structurally related iodinated amino acids with those of 123I-3-IMT. The aim was to select the optimal analog for oncologic imaging outside the brain. Methods: We studied 3-123I-iodotyrosine (123I-3-IT), 2-123I-iodotyrosine (123I-2-IT), 123I-iodo-azatyrosine (123I-IAzaT), 2-123I-iodophenylalanine (123I-2-IPhe), and 4-123I-iodophenylalanine (123I-4-IPhe). Tumor uptake and renal uptake in sarcoma-bearing rats were measured by use of in vivo dynamic imaging. The differential uptake ratio (average counts per pixel of the region of interest divided by the average counts per pixel inside the total body) and rates of tracer accumulation (K1 values) were calculated. Results were compared with the values obtained for 123I-3-IMT in the same rat. Tracers that demonstrated high tumor uptake were labeled with 125I and coinjected with 18F-FDG in rats with turpentine-induced acute inflammation. After 30 min, the rats were sacrificed and dissected. Amino acid tracer uptake in organs and tissues was measured, and the increase in uptake in the inflamed muscle was expressed relative to the increase in 18F-FDG uptake. Results: Tumor uptake and K1 values for 123I-2-IT and 123I-2-IPhe were comparable to those for 123I-3-IMT. 123I-4-IPhe showed high tumor uptake but a reduced K1 value because of high blood-pool activity. 123I-3-IT and 123I-IAzaT did not accumulate markedly in tumor tissue. Renal accumulation of 123I-2-IT, 123I-2-IPhe, and 123I-4-IPhe was at least 6 times lower than that of 123I-3-IMT. 18F-FDG uptake was markedly increased in areas of acute inflammation (215%). The increases for 125I-3-IMT and 125I-4-IPhe were 35.5% and 22.2%, respectively, of the increase for 18F-FDG. Almost no increase was found for 125I-2-IT (3.3%) and 125I-2-IPhe (2.8%). Conclusion: 123I-2-IT and 123I-2-IPhe are promising tracers for oncologic imaging outside the brain. 123I-2-IT has the advantage of an established kit for radiosynthesis.

Key Words: amino acids • tumor imaging • inflammation • biodistribution • small-animal imaging




This article has been cited by other articles:


Home page
JNMHome page
V. Kersemans, B. Cornelissen, K. Kersemans, M. Bauwens, E. Achten, R. A. Dierckx, J. Mertens, and G. Slegers
In Vivo Characterization of 123/125I-2-Iodo-L-Phenylalanine in an R1M Rhabdomyosarcoma Athymic Mouse Model as a Potential Tumor Tracer for SPECT
J. Nucl. Med., March 1, 2005; 46(3): 532 - 539.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K.-J. Langen and S. Broer
Molecular Transport Mechanisms of Radiolabeled Amino Acids for PET and SPECT
J. Nucl. Med., September 1, 2004; 45(9): 1435 - 1436.
[Full Text] [PDF]


Home page
JNMHome page
T. Lahoutte, V. Caveliers, S. M.R. Camargo, R. Franca, T. Ramadan, E. Veljkovic, J. Mertens, A. Bossuyt, and F. Verrey
SPECT and PET Amino Acid Tracer Influx via System L (h4F2hc-hLAT1) and Its Transstimulation
J. Nucl. Med., September 1, 2004; 45(9): 1591 - 1596.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.